Guidelines for radioiodine therapy of differentiated thyroid cancer

被引：0
|
作者：
M. Luster
S. E. Clarke
M. Dietlein
M. Lassmann
P. Lind
W. J. G. Oyen
J. Tennvall
E. Bombardieri
机构：
[1] University of Würzburg,Department of Nuclear Medicine
[2] Guys and St. Thomas Hospital,Department of Nuclear Medicine
[3] University of Cologne,Department of Nuclear Medicine and Endocrinology
[4] Positron Emission Tomography/Computed Tomography Centre,Department of Oncology
[5] Radboud University Nijmegen Medical Centre,undefined
[6] Lund University Hospital,undefined
[7] National Cancer Institute Foundation,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2008年 / 35卷
关键词：
Radioiodine therapy; Thyroid remnant ablation; Radioiodine treatment; Guidelines;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma
    Massimo Salvatori
    Markus Luster
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 821 - 828
  • [22] Differentiated thyroid cancer: radioiodine following lobectomy - a clinical feasibility study
    Hoyes, KR
    Owens, SE
    Millns, MM
    Allan, E
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (03) : 245 - 251
  • [23] Indications and results of radioiodine treatment of differentiated thyroid cancer
    Riemann, B.
    CHIRURG, 2020, 91 (12): : 1013 - 1016
  • [24] Radioiodine therapy reduces the frequency of circulating tumour cells in patients with differentiated thyroid cancer
    Schmidt, Mathias
    Antke, Christina
    Mattes-Gyorgy, Katalin
    Hautzel, Hubertus
    Allelein, Stephanie
    Haase, Matthias
    Dringenberg, Till
    Schott, Matthias
    Ehlers, Margret
    CLINICAL ENDOCRINOLOGY, 2021, 94 (06) : 1004 - 1011
  • [25] A Matter of Controversy: Is Radioiodine Therapy Favorable in Differentiated Thyroid Carcinoma?
    Schmidt, Matthias
    Goerges, Rainer
    Drzezga, Alexander
    Dietlein, Markus
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (08) : 1195 - 1201
  • [26] Radioiodine Therapy Induced Cytotoxicity in Patients with Differentiated Thyroid Carcinoma
    Hooman, A.
    Mogharrabi, M.
    Solooki, M.
    Mosaffa, N.
    Tabeie, F.
    Shafiee, B.
    Asli, Neshandar, I
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2008, 6 (03) : 135 - 139
  • [27] Postoperative thyroid remnants for differentiated thyroid cancer may not affect the outcome of high-dose radioiodine therapy
    Pan, Liqin
    Chen, Yanying
    Li, Sixiao
    Ouyang, Wei
    Feng, Huijuan
    Wu, Juqing
    Chen, Pan
    Deng, Yuying
    Wang, Jing
    Luo, Jiaxin
    Xian, Jialan
    ORAL ONCOLOGY, 2020, 104
  • [28] Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma
    Long, Bin
    Li, Linfa
    Yao, Lifang
    Chen, Shoucong
    Yi, Heqing
    Ye, Xuemei
    Xu, Dong
    Wu, Peng
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (08) : 244 - 247
  • [29] Development and validation of nomograms for predicting survival in differentiated thyroid cancer patients with or without radioiodine therapy
    Ran, Bingyu
    Gong, Jian
    Shang, Jingjie
    Wei, Feng
    Xu, Hao
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [30] Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications
    Van Nostrand, Douglas
    THYROID, 2018, 28 (09) : 1083 - 1093
12345